Up, Up & AwayThis is finally getting attention from investors proving again that patience is a virtue. Nice increase in volume too. Compelling value usually is noticed eventually. Still very cheap at~7 times forward EBITDA with cash to cover the maturing debs so no dilution. All this without stretching the balance sheet excessively. Shareholder equity/sh. should improve as the synergies are realized and factored into assets while debt is paid down.